This is very problematic in the situation of microdosing, given that consumers make up a self-picked sample with optimistic anticipations about the end result on the exercise [four, 57]. This positivity bias, coupled with the very low doses and self-assessment in the drug outcomes via scales and questionnaires, paves the way for a robust placebo re